Navigation Links
Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
Date:2/11/2008

- Sales Grow 73% over Same Quarter Last Year -

- FY08 Revenue Guidance Raised -

- Conference Call to be Held Today at 10:00 am Central Time -

MINNEAPOLIS, Feb. 11 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, today reported record net sales of $3.7 million for the third quarter of fiscal 2008 ended December 31, 2007, up 73% from $2.2 million in the year ago quarter. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales during the third fiscal quarter increased by approximately 65%.

For the three months ended December 31, 2007, sales to customers in the U.S. increased to $2.0 million from $396,000 in the year ago period. Sales to customers outside the U.S. for the three months ended December 31, 2007 and 2006 were $1.8 million in each period. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales to customers outside of the U.S. declined by approximately 10%.

"Our relatively new U.S. sales force has begun to hit stride by adding over 100 new customer relationships for the Urgent(R) PC neuromodulation system, bringing to more than 300 the total number of active U.S. customers who purchased our Urgent PC system or additional lead sets during our third fiscal quarter," said David B. Kaysen, Uroplasty's President and CEO. "As a result, we had exceptional third quarter revenue growth and are able to increase our revenue guidance for the full fiscal year. The Urgent PC is gaining rapid acceptance within our target market and doctors report very high patient satisfaction rates. Due to the strong growth in the third quarter in active customers for and the positive feedback on the Urgent PC, our sales team will focus a large amount of their time over the near term on building utilization
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Uroplasty to Host Third Quarter Conference Call on February 11
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Pipette.com has ... to their comprehensive portfolio of Eppendorf products. , ... to purchase a Centrifuge 5424/5424 R and receive the ... either Eppendorf Research plus or Eppendorf Reference 2 ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... , RESEARCH TRIANGLE PARK, N.C., July 22 ... it has completed its acquisition of Stiefel Laboratories, Inc. GSK has ... $2.9 billion. GSK also assumed $0.4 billion of net debt. ... additional cash payments of up to $0.3 billion depending on the future ...
... DUBAI, United Arab Emirates and SAN FRANCISCO, July 22 ... serving the Middle East, Africa, Turkey & Caspian regions, today ... supply agreement with Axcan Pharma for Pylera (R) , an ... pylori , a bacterium now recognized as being the main ...
... , CHICAGO, July 22 ... annual meeting today indicates that monitoring cardiac transplant patients with ... help clinicians to monitor cyclosporine-induced toxicity and adjust doses of ... , , In a scientific ...
Cached Biology Technology:GlaxoSmithKline Completes Acquisition of Stiefel 2NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region 2NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region 3Investigational Urine NGAL Biomarker Shows Promise to Monitor Cyclosporine Toxicity in Cardiac Transplant Patients 2
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
(Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, ... to eliminate the pain of trying to remember their usernames ... biometrics fused to their smartphones. To assist people who have ... the company that created 1U and focuses on redefining identity, ...
(Date:12/22/2014)... and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ) has ... Watermarking and Fingerprinting Markets" report to their ... This insight provides an overview of ... Watermarking aims to control and monitor piracy by ...
Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3The Global Watermarking and Fingerprinting Markets 2
... the familiar semi-aquatic bugs gliding across the lake at the ... walk on water. This was not always the case. ... unique arrangement of the legs, with the mid-legs greatly elongated. ... Evolutionary Biology have discovered the gene behind this evolutionary change. ...
... human brain distinctly separates the handling of images of ... image type in a different area of the brain. ... visual information in this manner to optimize processing the ... people who have been blind since birth the brain ...
... Sandbar, dusky and tiger sharks are among dozens of ... East Coast. Little is known about many of the species, ... scientists and fishery resource managers to monitor shark populations and ... Northeast Fisheries Science Center (NEFSC) lab in Narragansett, R.I., recently ...
Cached Biology News:Brain innately separates living and non-living objects for processing 2Scientists conduct shark survey off US East Coast 2Scientists conduct shark survey off US East Coast 3
Unique enzyme blend containing Taq and Pwo DNA Polymerase and another thermostable enzyme. The Expand 20 kbPLUS PCR System also includes an optimized reaction buffer, MgCl2 solution, and a human cont...
... Pfx DNA Polymerase is ideal for ... downstream applications such as cloning and ... by a proprietary enzyme preparation containing ... with proofreading (3'Cut Site5' exonuclease) activity. ...
... supply is a highly compact, extremely reliable and ... knob and one hi-lo range switch control the ... from 20 to 250 volts. One two-position switch ... voltage to output current. For maximum safety, the ...
... offers precision beveling of micropipette ... The unique abrasive plate drive ... greater control of the beveling ... very rapidly and produces consistent ...
Biology Products: